mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.5 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |